Calmer Canine® | The Solution to Canine Separation Anxiety

 

 

 

 

Technology and Research

Calmer Canine delivers microcurrents of targeted pulsed electromagnetic field (tPEMF) signals to the area of the brain involved in controlling emotions such as anxiety. Assisi is a global leader in the development of tPEMF technology with applications in veterinary medicine. Assisi has developed and conducted rigorous research on the Assisi Loop technology which is incorporated into our Loop and Loop Lounge products.

This highly effective technology has been used to treat pain and inflammation in over 50,000 animals to date across the US and internationally. Building off research conducted at Harvard University suggesting that tPEMF signals similar to that used in the Assisi Loop products were effective in treating people with mood disorders such as depression and anxiety, Assisi’s team of veterinarians, engineers and neurobiologists developed a new signal targeting the brain. This signal, delivered by Calmer Canine, is similar to that used in the Assisi Loop family of products, but it differs in certain key characteristics, e.g. the pulse frequency. Similar to the Assisi Loop product line, the Calmer Canine signal is sensation-free, very safe, and very effective. However, instead of targeting pain and inflammation in joints and soft tissues, Calmer Canine’s signal was tuned to a different target -controlling anxiety in the brain. The tPEMF signals are low level and of sufficient strength to affect cellular metabolism and signalling but are below the threshold to cause an action potential. They are invisible and cause no perceptible sensation.

 

Research Highlights and Results

Assisi completed a pilot study testing the efficacy of Calmer Canine on dogs with separation anxiety. All participating dogs showed a marked reduction of canine separation anxiety symptoms within four weeks of starting treatment. Some dogs showed significant effects within an even shorter timeframe. Many of the dogs in the study retained or even continued to improve after treatments had been discontinued, suggesting long-lasting effects of Calmer Canine treatment.

Affirming the results of the 2019 Calmer Canine pilot study, Assisi completed a placebo-controlled, double-blind North Carolina University Study in December 2021, conclusively demonstrating the independent efficacy of Calmer Canine to significantly reduce separation anxiety (CSA) in dogs. This breakthrough study found that, after just 4 weeks of using Calmer Canine, approximately two-thirds of participating dogs had a 100% or greater improvement in the time they spent relaxing versus anxious when home alone. Many of the dogs retained or even continued to improve after treatments had been discontinued, suggesting long-lasting effects of Calmer Canine.